4157.TWO · TAIGEN
Taiwan · RS rating 47 · As of 2026-10-08
| Price | 9.33 TWD |
|---|---|
| 1-day change | +9.1% |
| RS rating (overall / 1M / 3M / 12M) | 47 / 60 / 69 / 59 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 24 / 8 / 34 |
| Industry group (rank) | Medical-Biomed/Biotech (53) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -20.4% |
| Distance from 52-week high | +40.2% |
| Market cap (USD) | $192.8M |